Company / Return on Assets (ROA)
ANAPTYSBIO, INC Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-3.6%
FY2025
5-year range
-36.2% / -3.3%
FY2021-FY2025
Trend
+87.9%
vs FY2024
Sector context
#71 of 213
Health Care
What the data says
At -3.6%, ANAPTYSBIO, INC's return on assets (roa) ranks #71 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -36.2% in FY2023 to -1.6% in FY2017.
Based on SEC 10-K filings.
-3.6% in FY2025 with a 5-year CAGR of +11.2%.
Improved from -36.2% to -3.6% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -0.4pp
- 5-Year Change
- +11.2pp
- 10-Year Change
- -
Sector benchmark
#71 of 213 in Health CareTop 33% of 213This company -3.6% Sector average -24.1%
▼
+85.0% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 87.9% year-over-year.
- Currently 20.5pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2017.
- Lowest return on assets (roa) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.6% | +87.9% |
| FY2024 | -30.0% | +17.0% |
| FY2023 | -36.2% | -1006.1% |
| FY2022 | -3.3% | +78.4% |
| FY2021 | -15.1% | -2.3% |
| FY2020 | -14.8% | -114.2% |
| FY2019 | -6.9% | +42.9% |
| FY2018 | -12.1% | -638.4% |
| FY2017 | -1.6% | +76.1% |
| FY2016 | -6.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026